Drugs on Board: How Healthcare Providers Legally Engage with Patients and Employees Under the Influence

Drugs “On Board”: How Healthcare Providers Legally Engage

with Patients and Employees Under the Influence

January 11, 2019 | 9:00 a.m. - 12:15 p.m.

3 General CLE Credits | CLE# 2018-042

Registration: $115

Sponsored by the Healthcare Law Section

9:00 a.m.         Introduction by Section Co-Chairs

                        Barbra Z. Nault, Studebaker Nault PLLC, and Carolyn Heyman, Sedor Wendlandt Evans and Filippi

9:05 a.m.         Drug Use and Abuse in a Healthcare Workforce – Manage Risk to Protect Patients and Employers

                        Elizabeth P. Hodes, Partner, Davis Wright Tremaine, LLP

Ms. Hodes will present on the impact of Alaska’s opioid epidemic and legalization of marijuana on healthcare providers in the workplace.

10:00 a.m.       Protecting Patient Information and Knowing Provider Obligations – What is Required and What is Optional?

Clint Campion, Member/Owner, Sedor Wendlandt Evans and Filippi

Mr. Campion will present on provider confidentiality obligations related to patients under the influence, when a provider can or must call the police, best practices for responding to subpoenas, and provider obligations to testify regarding addiction in criminal, custody and/or guardianship cases.

11:00 a.m.       Break

11:15 a.m.       Drug Diversion Compliance – When, and to Whom, is Disclosure Required when Prescription Drugs are Diverted

                        Patrick Callahan, Associate, Davis Wright Tremaine, LLP

Mr. Callahan will present on the magnitude of the issue of prescription drug diversion, some of the common methods used to divert prescription drugs, best-practices and resources for avoiding diversion, and the reporting requirements when drug diversion occurs.

12:15 p.m.       Speaker evaluations and conclusion